[Congenital monoblastic leukemia and self-healing papulonodular cutaneous lesions].
Pujol
R M
RM
Service de Dermatologie et de Pédiatrie, Hospital de la Santa Cruz y San Pablo, Barcelona, Espagne.
Lopez
D
D
Badell
I
I
Alejo
M
M
Soler
J
J
Aventin
A
A
de Moragas
J M
JM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage; D003582:Cytogenetics; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007948:Leukemia, Monocytic, Acute / Q000150:complications / Q000151:congenital* / Q000188:drug therapy; D012074:Remission Induction; D012871:Skin Diseases / Q000150:complications / Q000151:congenital* / Q000188:drug therapy
D003561:Cytarabine; D005047:Etoposide; D003630:Daunorubicin
Leucémie monoblastique congénitale et lésions cutanées papulonodulaires auto-involutives.